Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

小池酸素工業

Mitsubishi Gas Chemical

Ube Material Industries

SEIKO PMC

堺化学工業

日華化学

ARAKAWA CHEMICAL INDUSTRIES

MAEZAWA KASEI INDUSTRIES

サンエー化研

Nihon Tokushu Toryo

Sekisui Plastics

Fukuvi Chemical Industry

TOC

SHOEI

NICHIBAN

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Statement Details: 医学生物学研究所 (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: 医学生物学研究所 (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 8 B  *  Net: ¥ 4 B  (Ratio: 49.38%)	[BS] 2010-03-31  *  Total: ¥ 8 B  *  Net: ¥ 4 B  (Ratio: 53.44%)	[BS] 2011-03-31  *  Total: ¥ 7 B  *  Net: ¥ 4 B  (Ratio: 52.96%)	[BS] 2012-03-31  *  Total: ¥ 8 B  *  Net: ¥ 4 B  (Ratio: 54.31%)	[BS] 2013-03-31  *  Total: ¥ 13 B  *  Net: ¥ 9 B  (Ratio: 68.67%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 6 B
Other Current Assets	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Tangible Assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Intangible Assets	¥ 414 M	¥ 456 M	¥ 391 M	¥ 317 M	¥ 428 M
Investment etc.	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Total Assets	¥ 8 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Current Liabilities	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Fixed Liabilities	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Capital surplus etc.	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Liabilities and net assets	¥ 8 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 5 B  *  Income: ¥ -1 B  (Ratio: -33.69%)	[PL] 2010-03-31  *  Sales: ¥ 6 B  *  Income: ¥ 266 M  (Ratio: 4.38%)	[PL] 2011-03-31  *  Sales: ¥ 6 B  *  Income: ¥ -112 M  (Ratio: -1.79%)	[PL] 2012-03-31  *  Sales: ¥ 6 B  *  Income: ¥ 318 M  (Ratio: 4.85%)	[PL] 2013-03-31  *  Sales: ¥ 6 B  *  Income: ¥ 213 M  (Ratio: 3.08%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Cost of Sales	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Gross profit	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Other income	¥ 71 M	¥ 73 M	¥ 46 M	¥ 104 M	¥ 169 M
SG&A	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Other expenses	¥ 2 B	¥ 284 M	¥ 550 M	¥ 166 M	¥ 195 M
Net income	¥ -1 B	¥ 266 M	¥ -112 M	¥ 318 M	¥ 213 M
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2009-03-31  *  OCF: ¥ 737 M  *  Cash: ¥ +198 M	[CF] 2010-03-31  *  OCF: ¥ 629 M  *  Cash: ¥ -78 M	[CF] 2011-03-31  *  OCF: ¥ 599 M  *  Cash: ¥ -20 M	[CF] 2012-03-31  *  OCF: ¥ 670 M  *  Cash: ¥ -30 M	[CF] 2013-03-31  *  OCF: ¥ 351 M  *  Cash: ¥ +4 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF	¥ 737 M	¥ 629 M	¥ 599 M	¥ 670 M	¥ 351 M
Investment CF	¥ -1 B	¥ -226 M	¥ -394 M	¥ -424 M	¥ -354 M
Financial CF	¥ 818 M	¥ -452 M	¥ -160 M	¥ -229 M	¥ 4 B
Foreign Exchange Effects	¥ -45 M	¥ -28 M	¥ -65 M	¥ -47 M	¥ 14 M
Net Change in Cash	¥ 198 M	¥ -78 M	¥ -20 M	¥ -30 M	¥ 4 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ -1 B  *  Net: ¥ -2 B	[SS] 2010-03-31  *  Income: ¥ 266 M  *  Net: ¥ +297 M	[SS] 2011-03-31  *  Income: ¥ -112 M  *  Net: ¥ -171 M	[SS] 2012-03-31  *  Income: ¥ 318 M  *  Net: ¥ +331 M	[SS] 2013-03-31  *  Income: ¥ 213 M  *  Net: ¥ +4 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares	-	-	-	-	¥ 4 B
Dividends from surplus	¥ -69 M	-	¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ -1 B	¥ 266 M	¥ -112 M	¥ 318 M	¥ 213 M
Purchase of treasury stock	¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ 378 K
Other Change in Stockholders Equity	¥ 13 M	¥ 164 K	-	¥ 4 M	¥ -1 K
Other Change in Net Assets	¥ -65 M	¥ 30 M	¥ 10 M	¥ 76 M	¥ -7 M
Net Change in Net Assets	¥ -2 B	¥ 297 M	¥ -171 M	¥ 331 M	¥ 4 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 7 B  *  Net: ¥ 4 B  (Ratio: 50.81%)	[BS] 2010-03-31  *  Total: ¥ 8 B  *  Net: ¥ 4 B  (Ratio: 55.22%)	[BS] 2011-03-31  *  Total: ¥ 7 B  *  Net: ¥ 4 B  (Ratio: 54.73%)	[BS] 2012-03-31  *  Total: ¥ 8 B  *  Net: ¥ 4 B  (Ratio: 56.17%)	[BS] 2013-03-31  *  Total: ¥ 13 B  *  Net: ¥ 9 B  (Ratio: 70.29%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 5 B
Other Current Assets	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Tangible Assets	¥ 835 M	¥ 829 M	¥ 879 M	¥ 923 M	¥ 986 M
Intangible Assets	¥ 110 M	¥ 216 M	¥ 212 M	¥ 196 M	¥ 371 M
Investment etc.	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Total Assets	¥ 7 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Current Liabilities	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Fixed Liabilities	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Capital surplus etc.	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Liabilities and net assets	¥ 7 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 5 B  *  Income: ¥ -2 B  (Ratio: -53.71%)	[PL] 2010-03-31  *  Sales: ¥ 5 B  *  Income: ¥ 372 M  (Ratio: 7.16%)	[PL] 2011-03-31  *  Sales: ¥ 5 B  *  Income: ¥ -51 M  (Ratio: -0.93%)	[PL] 2012-03-31  *  Sales: ¥ 5 B  *  Income: ¥ 257 M  (Ratio: 4.46%)	[PL] 2013-03-31  *  Sales: ¥ 5 B  *  Income: ¥ 232 M  (Ratio: 3.90%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Cost of Sales	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Gross profit	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Other income	¥ 79 M	¥ 191 M	¥ 54 M	¥ 104 M	¥ 174 M
SG&A	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B
Other expenses	¥ 3 B	¥ 263 M	¥ 432 M	¥ 204 M	¥ 152 M
Net income	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ -2 B  *  Net: ¥ -2 B	[SS] 2010-03-31  *  Income: ¥ 372 M  *  Net: ¥ +413 M	[SS] 2011-03-31  *  Income: ¥ -51 M  *  Net: ¥ -116 M	[SS] 2012-03-31  *  Income: ¥ 257 M  *  Net: ¥ +253 M	[SS] 2013-03-31  *  Income: ¥ 232 M  *  Net: ¥ +4 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares	-	-	-	-	¥ 4 B
Dividends from surplus	¥ -69 M	-	¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Purchase of treasury stock	¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ 378 K
Other Change in Stockholders Equity	¥ -2 K	¥ -1 K	¥ -1 K	¥ -1 K	¥ 1 K
Other Change in Net Assets	¥ -29 M	¥ 41 M	¥ 4 M	¥ 64 M	¥ 69 M
Net Change in Net Assets	¥ -2 B	¥ 413 M	¥ -116 M	¥ 253 M	¥ 4 B

---

Consolidated :Balance sheet (BS) Non-Consolidated | Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 6 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 9 B
Cash and deposits	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 6 B
Notes and accounts receivable-trade	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Short-term investment securities	¥ 21 M	¥ 22 M	¥ 1 M	¥ 3 M	¥ 23 M	¥ 6 M
Merchandise and finished goods		¥ 453 M	¥ 759 M	¥ 603 M	¥ 631 M	¥ 661 M
Raw materials and supplies		¥ 350 M	¥ 300 M	¥ 299 M	¥ 340 M	¥ 414 M
Work in process		¥ 791 M	¥ 513 M	¥ 555 M	¥ 557 M	¥ 540 M
Allowance for doubtful accounts	¥ -53 M	¥ -177 M	¥ -13 M	¥ -15 M	¥ -18 M	¥ -2 M
Other	¥ 187 M	¥ 315 M	¥ 127 M	¥ 90 M	¥ 176 M	¥ 158 M
Current assets	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 10 B
Buildings and structures	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Accumulated depreciation	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Buildings and structures, net	¥ 627 M	¥ 676 M	¥ 631 M	¥ 586 M	¥ 565 M	¥ 565 M
Machinery, equipment and vehicles	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Accumulated depreciation	¥ -954 M	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Machinery, equipment and vehicles, net	¥ 228 M	¥ 169 M	¥ 126 M	¥ 89 M	¥ 77 M	¥ 88 M
Land	¥ 44 M	¥ 54 M	¥ 55 M	¥ 53 M	¥ 53 M	¥ 54 M
Lease assets		¥ 64 M	¥ 110 M	¥ 125 M	¥ 154 M	¥ 269 M
Accumulated depreciation		¥ -13 M	¥ -19 M	¥ -30 M	¥ -46 M	¥ -79 M
Lease assets, net		¥ 50 M	¥ 90 M	¥ 94 M	¥ 107 M	¥ 189 M
Construction in progress				¥ 27 M	¥ 73 M	¥ 54 M
Other	¥ 282 M	¥ 517 M	¥ 653 M	¥ 834 M	¥ 952 M	¥ 1 B
Accumulated depreciation	¥ -239 M	¥ -416 M	¥ -477 M	¥ -594 M	¥ -711 M	¥ -911 M
Other, net	¥ 42 M	¥ 100 M	¥ 175 M	¥ 240 M	¥ 241 M	¥ 291 M
Property, plant and equipment	¥ 943 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Goodwill	¥ 46 M	¥ 281 M	¥ 223 M	¥ 163 M	¥ 107 M	¥ 158 M
Lease assets			¥ 4 M	¥ 4 M	¥ 21 M	¥ 16 M
Other	¥ 104 M	¥ 132 M	¥ 229 M	¥ 223 M	¥ 188 M	¥ 254 M
Intangible assets	¥ 150 M	¥ 414 M	¥ 456 M	¥ 391 M	¥ 317 M	¥ 428 M
Investment securities	¥ 1 B	¥ 420 M	¥ 284 M	¥ 227 M	¥ 270 M	¥ 339 M
Long-term loans receivable	¥ 92 M	¥ 145 M	¥ 354 M	¥ 332 M	¥ 402 M	¥ 437 M
Long-term prepaid expenses	¥ 544 M	¥ 344 M	¥ 323 M	¥ 320 M	¥ 283 M	¥ 363 M
Other	¥ 568 M	¥ 620 M	¥ 612 M	¥ 585 M	¥ 594 M	¥ 279 M
Allowance for doubtful accounts	¥ -55 M	¥ -101 M	¥ -230 M	¥ -254 M	¥ -230 M	¥ -224 M
Investments and other assets	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Noncurrent assets	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Assets	¥ 9 B	¥ 8 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Notes and accounts payable-trade	¥ 158 M	¥ 154 M	¥ 220 M	¥ 262 M	¥ 356 M	¥ 348 M
Deferred tax liabilities					-	¥ 197 K
Lease obligations		¥ 5 M	¥ 10 M	¥ 14 M	¥ 22 M	¥ 48 M
Income taxes payable	¥ 41 M	¥ 26 M	¥ 24 M	¥ 28 M	¥ 41 M	¥ 23 M
Short-term loans payable	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Other	¥ 283 M	¥ 334 M	¥ 355 M	¥ 308 M	¥ 396 M	¥ 534 M
Current liabilities	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Long-term loans payable	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Lease obligations		¥ 12 M	¥ 43 M	¥ 49 M	¥ 63 M	¥ 117 M
Deferred tax liabilities					-	¥ 7 M
Other	¥ 82 M	¥ 154 M	¥ 116 M	¥ 110 M	¥ 118 M	¥ 82 M
Noncurrent liabilities	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Liabilities	¥ 2 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Capital surplus	¥ 3 B	¥ 3 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 4 B
Retained earnings	¥ 730 M	¥ -1 B	¥ 378 M	¥ 196 M	¥ 451 M	¥ 596 M
Treasury stock	¥ -1 M	¥ -42 M	¥ -42 M	¥ -43 M	¥ -43 M	¥ -43 M
Shareholders' equity	¥ 6 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 9 B
Valuation difference on available-for-sale securities	¥ -70 M	¥ -102 M	¥ -58 M	¥ -55 M	¥ 14 M	¥ 74 M
Deferred gains or losses on hedges	¥ -23 M	¥ -29 M	¥ -34 M	¥ -34 M	¥ -10 M	-
Foreign currency translation adjustment	¥ -30 M	¥ -63 M	¥ -81 M	¥ -75 M	¥ -64 M	¥ -143 M
Valuation and translation adjustments	¥ -124 M	¥ -196 M	¥ -174 M	¥ -165 M	¥ -60 M	¥ -69 M
Subscription rights to shares	¥ 40 M	¥ 44 M	¥ 43 M	¥ 43 M	¥ 14 M	¥ 14 M
Minority interests	¥ 7 M	¥ 10 M	¥ 20 M	¥ 21 M	¥ 22 M	¥ 24 M
Liabilities and net assets	¥ 9 B	¥ 8 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Inventories	¥ 1 B
Deferred tax assets	¥ 87 M
Deferred tax assets	¥ 83 M
Consolidated :Income statement (PL) Non-Consolidated | Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 5 B	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Operating income	¥ 102 M	¥ 315 M	¥ 479 M	¥ 395 M	¥ 381 M	¥ 238 M
Ordinary income	¥ -4 M	¥ 135 M	¥ 322 M	¥ 195 M	¥ 309 M	¥ 319 M
Net income	¥ -195 M	¥ -1 B	¥ 266 M	¥ -112 M	¥ 318 M	¥ 213 M
Comprehensive income				¥ -102 M	¥ 425 M	¥ 205 M
Cost of sales	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Selling, general and administrative expenses	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Gross profit	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Interest income	¥ 37 M	¥ 33 M	¥ 12 M	¥ 9 M	¥ 8 M	¥ 7 M
Foreign exchange gains					-	¥ 142 M
Compensation income				-	¥ 14 M	-
Insurance premiums refunded cancellation				-	¥ 7 M	-
Dividends income of insurance	¥ 3 M	¥ 4 M	¥ 6 M	¥ 4 M	¥ 6 M	¥ 4 M
Other	¥ 7 M	¥ 10 M	¥ 14 M	¥ 14 M	¥ 12 M	¥ 12 M
Non-operating income	¥ 57 M	¥ 48 M	¥ 33 M	¥ 28 M	¥ 50 M	¥ 167 M
Interest expenses	¥ 21 M	¥ 36 M	¥ 58 M	¥ 42 M	¥ 45 M	¥ 40 M
Equity in losses of affiliates	¥ 104 M	¥ 32 M	¥ 60 M	¥ 44 M	¥ 37 M	¥ 15 M
Stock issuance cost					-	¥ 26 M
Foreign exchange losses	¥ 22 M	¥ 155 M	¥ 56 M	¥ 128 M	¥ 38 M	-
Other	¥ 523 K	¥ 1 M	¥ 408 K	¥ 3 M	¥ 552 K	¥ 3 M
Non-operating expenses	¥ 165 M	¥ 229 M	¥ 190 M	¥ 228 M	¥ 122 M	¥ 85 M
Gain on sales of noncurrent assets			¥ 38 K		-	¥ 1 M
Gain on sales of investment securities	¥ 86 M	¥ 3 M	¥ 2 M	¥ 3 M	¥ 17 M	¥ 870 K
State subsidy		¥ 1 M	¥ 33 M	¥ 13 M	¥ 6 M	-
Gain on reversal of subscription rights to shares		¥ 382 K	¥ 573 K		¥ 29 M	-
Other					-	¥ 39 K
Extraordinary income	¥ 88 M	¥ 23 M	¥ 39 M	¥ 17 M	¥ 54 M	¥ 2 M
Impairment loss		¥ 494 M			-	¥ 54 M
Loss on retirement of noncurrent assets	¥ 2 M	¥ 25 M	¥ 5 M	¥ 3 M	¥ 4 M	¥ 2 M
Loss on valuation of investment securities		¥ 1 B	¥ 17 M	¥ 10 M	-	¥ 7 M
Extraordinary loss	¥ 207 M	¥ 1 B	¥ 23 M	¥ 249 M	¥ 4 M	¥ 64 M
Income before income taxes	¥ -123 M	¥ -1 B	¥ 338 M	¥ -35 M	¥ 358 M	¥ 257 M
Income taxes	¥ 71 M	¥ 142 M	¥ 70 M	¥ 73 M	¥ 38 M	¥ 45 M
Income taxes-current	¥ 42 M	¥ 31 M	¥ 70 M	¥ 73 M	¥ 38 M	¥ 45 M
Income before minority interests				¥ -109 M	¥ 319 M	¥ 212 M
Minority interests in income	¥ 447 K	¥ 3 M	¥ 1 M	¥ 3 M	¥ 1 M	¥ -930 K
Valuation difference on available-for-sale securities				¥ 2 M	¥ 70 M	¥ 59 M
Deferred gains or losses on hedges				¥ 330 K	¥ 23 M	¥ 10 M
Foreign currency translation adjustment				¥ 4 M	¥ 11 M	¥ -76 M
Other comprehensive income				¥ 6 M	¥ 105 M	¥ -6 M
Comprehensive income attributable to owners of the parent				¥ -104 M	¥ 424 M	¥ 204 M
Comprehensive income attributable to minority interests				¥ 1 M	¥ 1 M	¥ 1 M
Loss on investments in partnership	¥ 1 M	¥ 2 M	¥ 14 M	¥ 9 M	-
Reversal of allowance for doubtful accounts		¥ 1 M	¥ 2 M	¥ 1 M	-
Loss on sales of investment securities	¥ 33 M			¥ 364 K	-
Restructuring loss				¥ 203 M	-
Provision of allowance for doubtful accounts	¥ 54 M	¥ 214 M		¥ 31 M	-
Gain on change in equity	¥ 2 M	¥ 16 M
Loss on valuation of inventories	¥ 117 M	¥ 173 M
Income taxes-deferred	¥ 28 M	¥ 110 M
Land and house rent received	¥ 9 M
Cost of lease revenue	¥ 14 M
Consolidated :Cash flow statement (CF) Non-Consolidated | Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Cash flow statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Subtotal	¥ 576 M	¥ 843 M	¥ 719 M	¥ 705 M	¥ 752 M	¥ 420 M
Impairment loss		¥ 494 M			-	¥ 54 M
Amortization of goodwill	¥ 15 M	¥ 38 M	¥ 59 M	¥ 59 M	¥ 60 M	¥ 61 M
Increase (decrease) in allowance for doubtful accounts	¥ 98 M	¥ 169 M	¥ -35 M	¥ 26 M	¥ -21 M	¥ -21 M
Interest and dividends income	¥ -42 M	¥ -34 M	¥ -13 M	¥ -10 M	¥ -8 M	¥ -8 M
Interest expenses	¥ 21 M	¥ 36 M	¥ 58 M	¥ 42 M	¥ 45 M	¥ 40 M
Foreign exchange losses (gains)	¥ 17 M	¥ 90 M	¥ 82 M	¥ 150 M	¥ 70 M	¥ -137 M
Equity in (earnings) losses of affiliates	¥ 104 M	¥ 32 M	¥ 60 M	¥ 44 M	¥ 37 M	¥ 15 M
Decrease (increase) in notes and accounts receivable-trade	¥ 82 M	¥ 90 M	¥ -133 M	¥ -114 M	¥ -233 M	¥ -112 M
Decrease (increase) in inventories	¥ 21 M	¥ 70 M	¥ 26 M	¥ -124 M	¥ -64 M	¥ -30 M
Increase (decrease) in notes and accounts payable-trade	¥ -34 M	¥ -13 M	¥ 68 M	¥ 80 M	¥ 96 M	¥ -20 M
Loss (gain) on sales of investment securities	¥ -53 M	¥ -3 M	¥ -2 M	¥ -2 M	¥ -17 M	¥ -870 K
Depreciation and other amortization				¥ 342 M	¥ 352 M	¥ 373 M
Loss (gain) on valuation of investment securities		¥ 1 B	¥ 17 M	¥ 10 M	-	¥ 7 M
Loss (gain) on sales and retirement of noncurrent assets	¥ 2 M	¥ 25 M	¥ 5 M	¥ 3 M	¥ 4 M	¥ 1 M
Loss (gain) on investments in partnership	¥ 1 M	¥ 2 M	¥ 18 M	¥ 12 M	¥ -3 M	¥ 5 M
Stock issuance cost					-	¥ 26 M
Gain on reversal of subscription rights to shares				-	¥ -29 M	-
Increase (decrease) in accounts payable-other	¥ -34 M	¥ 6 M	¥ -62 M	¥ 3 M	¥ 90 M	¥ -9 M
Decrease (increase) in claims provable in bankruptcy, claims provable in rehabilitation				¥ -2 M	¥ -375 K	¥ 2 M
Decrease (increase) in other current assets	¥ -6 M	¥ 30 M	¥ -64 M	¥ 24 M	¥ -33 M	¥ -47 M
Increase (decrease) in other current liabilities	¥ 12 M	¥ -9 M	¥ 17 M	¥ -13 M	¥ 40 M	¥ -39 M
Other, net	¥ -1 M	¥ 3 M	¥ 49 K	¥ 4 M	¥ 7 M	¥ 4 M
Interest and dividends income received	¥ 42 M	¥ 33 M	¥ 14 M	¥ 10 M	¥ 8 M	¥ 7 M
Interest expenses paid	¥ -23 M	¥ -50 M	¥ -48 M	¥ -41 M	¥ -43 M	¥ -39 M
Income taxes paid	¥ -34 M	¥ -89 M	¥ -55 M	¥ -74 M	¥ -46 M	¥ -37 M
Net cash provided by (used in) operating activities	¥ 559 M	¥ 737 M	¥ 629 M	¥ 599 M	¥ 670 M	¥ 351 M
Purchase of property, plant and equipment	¥ -94 M	¥ -108 M	¥ -155 M	¥ -258 M	¥ -240 M	¥ -335 M
Proceeds from sales of property, plant and equipment			¥ 348 K		-	¥ 1 M
Purchase of investment securities	¥ -106 M	¥ -53 M	¥ -52 M	¥ -756 K	¥ -1 M	¥ -21 M
Proceeds from sales of investment securities	¥ 28 M	¥ 18 M	¥ 197 M	¥ 40 M	¥ 32 M	¥ 14 M
Payments of loans receivable	¥ -147 M	¥ -158 M	¥ -100 M	¥ -30 M	¥ -206 M	¥ -65 M
Collection of loans receivable	¥ 3 M	¥ 23 M	¥ 39 M	¥ 8 M	¥ 42 M	¥ 18 M
Purchase of intangible assets	¥ -21 M	¥ -67 M	¥ -148 M	¥ -49 M	¥ -29 M	¥ -113 M
Payments into time deposits		¥ -70 M		¥ -10 M	¥ -10 M	¥ -10 M
Proceeds from withdrawal of time deposits			¥ 70 M		¥ 10 M	¥ 310 M
Purchase of stocks of subsidiaries and affiliates	¥ -87 M	¥ -582 M	¥ -9 M		¥ -1 M	¥ -5 M
Proceeds from sales of stocks of subsidiaries and affiliates	¥ 94 M			-	¥ 13 K	-
Decrease (increase) in other investments					-	¥ -144 M
Other, net	¥ -85 M	¥ -255 M	¥ -12 M	¥ -96 M	¥ -19 M	-
Net cash provided by (used in) investing activities	¥ -476 M	¥ -1 B	¥ -226 M	¥ -394 M	¥ -424 M	¥ -354 M
Proceeds from long-term loans payable	¥ 849 M	¥ 1 B	¥ 559 M	¥ 824 M	¥ 819 M	¥ 1 B
Repayment of long-term loans payable	¥ -508 M	¥ -718 M	¥ -857 M	¥ -903 M	¥ -832 M	¥ -1 B
Proceeds from issuance of common stock					-	¥ 4 B
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Cash dividends paid	¥ -69 M	¥ -69 M	¥ -406 K	¥ -67 M	¥ -68 M	¥ -68 M
Net increase (decrease) in short-term loans payable	¥ 64 M	¥ -52 M	¥ -158 M		¥ -130 M	¥ 100 M
Cash dividends paid to minority shareholders				¥ -146 K	¥ -1 M	¥ -371 K
Repayments of lease obligations		¥ -840 K	¥ -3 M	¥ -12 M	¥ -17 M	¥ -33 M
Proceeds from sales of treasury stock					-	¥ 224 K
Net cash provided by (used in) financing activities	¥ 335 M	¥ 818 M	¥ -452 M	¥ -160 M	¥ -229 M	¥ 4 B
Effect of exchange rate change on cash and cash equivalents	¥ -13 M	¥ -45 M	¥ -28 M	¥ -65 M	¥ -47 M	¥ 14 M
Net increase (decrease) in cash and cash equivalents	¥ 405 M	¥ 198 M	¥ -78 M	¥ -20 M	¥ -30 M	¥ 4 B
Increase in cash and cash equivalents from newly consolidated subsidiary		¥ 61 M		-	¥ 7 M	-
Increase in cash and cash equivalents resulting from merger					-	¥ 9 M
Cash and cash equivalents	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 6 B
Loss on business restructuring				¥ 203 M	-
Depreciation and amortization	¥ 362 M	¥ 401 M	¥ 276 M	¥ 342 M
Payments for investments in capital of subsidiaries and affiliates		¥ -60 M	¥ -60 M
Collection of investments in capital			¥ 4 M	¥ 1 M
Proceeds from stock issuance to minority shareholders			¥ 7 M
Share-based compensation expenses	¥ 15 M	¥ 3 M
Loss on valuation of inventories	¥ 117 M	¥ 173 M
Loss (gain) on change in equity	¥ -2 M	¥ -16 M
Consolidated :Shareowners' equity (SS) Non-Consolidated | Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares					-	¥ 2 B
Total changes of items during the period					-	¥ 2 B
Issuance of new shares					-	¥ 2 B
Disposal of treasury stock					-	¥ 550 K
Total changes of items during the period			¥ -1 B		-	¥ 2 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Change of scope of equity method	¥ -7 M	¥ 13 M		-	¥ 4 M	-
Total changes of items during the period	¥ -272 M	¥ -2 B	¥ 1 B	¥ -181 M	¥ 254 M	¥ 144 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 495 K
Total changes of items during the period		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -172 K
Issuance of new shares					-	¥ 4 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ -195 M	¥ -1 B	¥ 266 M	¥ -112 M	¥ 318 M	¥ 213 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 1 M
Change of scope of equity method	¥ -7 M	¥ 13 M		-	¥ 4 M	-
Total changes of items during the period	¥ -272 M	¥ -2 B	¥ 266 M	¥ -182 M	¥ 254 M	¥ 4 B
Net changes of items other than shareholders' equity	¥ -50 M	¥ -32 M	¥ 44 M	¥ 2 M	¥ 70 M	¥ 59 M
Total changes of items during the period	¥ -50 M	¥ -32 M	¥ 44 M	¥ 2 M	¥ 70 M	¥ 59 M
Net changes of items other than shareholders' equity	¥ -29 M	¥ -6 M	¥ -4 M	¥ 330 K	¥ 23 M	¥ 10 M
Total changes of items during the period	¥ -29 M	¥ -6 M	¥ -4 M	¥ 330 K	¥ 23 M	¥ 10 M
Net changes of items other than shareholders' equity	¥ -12 M	¥ -33 M	¥ -18 M	¥ 5 M	¥ 11 M	¥ -79 M
Total changes of items during the period	¥ -12 M	¥ -33 M	¥ -18 M	¥ 5 M	¥ 11 M	¥ -79 M
Net changes of items other than shareholders' equity	¥ -92 M	¥ -71 M	¥ 21 M	¥ 8 M	¥ 105 M	¥ -9 M
Total changes of items during the period	¥ -92 M	¥ -71 M	¥ 21 M	¥ 8 M	¥ 105 M	¥ -9 M
Net changes of items other than shareholders' equity	¥ 15 M	¥ 3 M	¥ -573 K		¥ -29 M	-
Total changes of items during the period	¥ 15 M	¥ 3 M	¥ -573 K		¥ -29 M	-
Net changes of items other than shareholders' equity	¥ -1 M	¥ 2 M	¥ 9 M	¥ 1 M	¥ 837 K	¥ 1 M
Total changes of items during the period	¥ -1 M	¥ 2 M	¥ 9 M	¥ 1 M	¥ 837 K	¥ 1 M
Issuance of new shares					-	¥ 4 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ -195 M	¥ -1 B	¥ 266 M	¥ -112 M	¥ 318 M	¥ 213 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 1 M
Change of scope of equity method	¥ -7 M	¥ 13 M		-	¥ 4 M	-
Net changes of items other than shareholders' equity	¥ -78 M	¥ -65 M	¥ 30 M	¥ 10 M	¥ 76 M	¥ -7 M
Total changes of items during the period	¥ -350 M	¥ -2 B	¥ 297 M	¥ -171 M	¥ 331 M	¥ 4 B
Deficit disposition			¥ -1 B
Increase by merger			¥ 163 K
Deficit disposition			¥ 1 B
Increase by merger			¥ 163 K
Increase by merger			¥ 163 K
Deficit disposition
Deficit disposition

Non-Consolidated :Balance sheet (BS) Non-Consolidated | Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 6 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 9 B
Cash and deposits	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 5 B
Notes receivable-trade	¥ 268 M	¥ 269 M	¥ 251 M	¥ 250 M	¥ 262 M	¥ 245 M
Accounts receivable-trade	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Short-term investment securities	¥ 21 M	¥ 22 M	¥ 1 M	¥ 3 M	¥ 4 M	¥ 6 M
Merchandise and finished goods		¥ 496 M	¥ 521 M	¥ 611 M	¥ 605 M	¥ 653 M
Raw materials and supplies		¥ 319 M	¥ 235 M	¥ 250 M	¥ 289 M	¥ 365 M
Work in process	¥ 569 M	¥ 446 M	¥ 483 M	¥ 516 M	¥ 532 M	¥ 514 M
Advance payments-trade	¥ 18 M	¥ 33 M	¥ 29 M	¥ 2 M	¥ 5 M	¥ 1 M
Prepaid expenses	¥ 3 M	¥ 9 M	¥ 5 M	¥ 5 M	¥ 9 M	¥ 6 M
Short-term loans receivable	¥ 166 M	¥ 235 M	¥ 160 M	¥ 30 M	¥ 104 M	¥ 5 M
Accounts receivable-other	¥ 118 M	¥ 78 M	¥ 143 M	¥ 145 M	¥ 66 M	¥ 137 M
Allowance for doubtful accounts	¥ -54 M	¥ -306 M	¥ -279 M	¥ -159 M	¥ -86 M	¥ -71 M
Other	¥ 17 M	¥ 39 M	¥ 83 M	¥ 80 M	¥ 61 M	¥ 53 M
Current assets	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 9 B
Buildings	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Accumulated depreciation	¥ -975 M	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Buildings, net	¥ 613 M	¥ 581 M	¥ 542 M	¥ 510 M	¥ 494 M	¥ 492 M
Structures	¥ 59 M	¥ 73 M	¥ 73 M	¥ 73 M	¥ 73 M	¥ 73 M
Accumulated depreciation	¥ -45 M	¥ -49 M	¥ -52 M	¥ -56 M	¥ -59 M	¥ -61 M
Structures, net	¥ 13 M	¥ 24 M	¥ 20 M	¥ 16 M	¥ 14 M	¥ 11 M
Machinery and equipment	¥ 1 B	¥ 985 M	¥ 980 M	¥ 952 M	¥ 932 M	¥ 1 B
Accumulated depreciation	¥ -859 M	¥ -861 M	¥ -894 M	¥ -890 M	¥ -886 M	¥ -1 B
Machinery and equipment, net	¥ 185 M	¥ 123 M	¥ 86 M	¥ 62 M	¥ 46 M	¥ 58 M
Vehicles	¥ 425 K	¥ 425 K	¥ 425 K	¥ 425 K	¥ 425 K	¥ 425 K
Accumulated depreciation	¥ -44 K	¥ -282 K	¥ -371 K	¥ -404 K	¥ -424 K	¥ -424 K
Vehicles, net	¥ 380 K	¥ 142 K	¥ 53 K	¥ 20 K	-	-
Tools, furniture and fixtures	¥ 261 M	¥ 279 M	¥ 359 M	¥ 504 M	¥ 640 M	¥ 888 M
Accumulated depreciation	¥ -229 M	¥ -227 M	¥ -268 M	¥ -342 M	¥ -449 M	¥ -648 M
Tools, furniture and fixtures, net	¥ 32 M	¥ 52 M	¥ 90 M	¥ 161 M	¥ 190 M	¥ 239 M
Land	¥ 44 M	¥ 44 M	¥ 44 M	¥ 44 M	¥ 44 M	¥ 44 M
Lease assets		¥ 8 M	¥ 51 M	¥ 71 M	¥ 90 M	¥ 199 M
Accumulated depreciation		¥ -894 K	¥ -5 M	¥ -16 M	¥ -31 M	¥ -60 M
Lease assets, net		¥ 8 M	¥ 46 M	¥ 54 M	¥ 59 M	¥ 138 M
Construction in progress				¥ 27 M	¥ 73 M	-
Property, plant and equipment	¥ 889 M	¥ 835 M	¥ 829 M	¥ 879 M	¥ 923 M	¥ 986 M
Patent right	¥ 12 M	¥ 20 M	¥ 132 M	¥ 122 M	¥ 103 M	¥ 84 M
Leasehold right	¥ 3 M	¥ 3 M	¥ 3 M	¥ 3 M	¥ 3 M	¥ 3 M
Right of trademark			¥ 400 K	¥ 357 K	¥ 314 K	¥ 272 K
Software	¥ 71 M	¥ 80 M	¥ 69 M	¥ 75 M	¥ 62 M	¥ 147 M
Goodwill					-	¥ 112 M
Lease assets			¥ 4 M	¥ 4 M	¥ 21 M	¥ 16 M
Telephone subscription right	¥ 5 M	¥ 5 M	¥ 5 M	¥ 5 M	¥ 5 M	¥ 5 M
Intangible assets	¥ 93 M	¥ 110 M	¥ 216 M	¥ 212 M	¥ 196 M	¥ 371 M
Investment securities	¥ 1 B	¥ 373 M	¥ 245 M	¥ 199 M	¥ 256 M	¥ 305 M
Stocks of subsidiaries and affiliates	¥ 990 M	¥ 540 M	¥ 548 M	¥ 302 M	¥ 218 M	¥ 189 M
Bonds of subsidiaries and affiliates					-	¥ 21 M
Investments in capital of subsidiaries and affiliates	¥ 120 M	¥ 174 M	¥ 242 M	¥ 212 M	¥ 191 M	¥ 176 M
Long-term loans receivable		¥ 28 M	¥ 190 M	¥ 190 M	¥ 286 M	¥ 280 M
Long-term loans receivable from subsidiaries and affiliates	¥ 312 M	¥ 988 M	¥ 1 B	¥ 1 B	¥ 893 M	¥ 1 B
Long-term loans receivable from employees	¥ 34 M	¥ 41 M	¥ 34 M	¥ 30 M	¥ 26 M	¥ 22 M
Claims provable in bankruptcy, claims provable in rehabilitation and other				¥ 2 M	¥ 2 M	-
Long-term prepaid expenses	¥ 329 M	¥ 8 M	¥ 12 M	¥ 92 M	¥ 139 M	¥ 324 M
Long-term time deposits	¥ 300 M	¥ 300 M	¥ 300 M	¥ 300 M	¥ 300 M	-
Insurance funds	¥ 101 M	¥ 101 M	¥ 88 M	¥ 88 M	¥ 70 M	¥ 68 M
Membership	¥ 1 M	¥ 1 M	¥ 1 M	¥ 1 M	¥ 1 M	¥ 1 M
Guarantee deposits	¥ 57 M	¥ 58 M	¥ 57 M	¥ 55 M	¥ 56 M	¥ 55 M
Long-term accounts receivable-other				¥ 70 M	¥ 294 M	¥ 277 M
Allowance for doubtful accounts	¥ -3 M	¥ -69 M	¥ -273 M	¥ -466 M	¥ -559 M	¥ -581 M
Investments and other assets	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Noncurrent assets	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Assets	¥ 9 B	¥ 7 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Accounts payable-trade	¥ 197 M	¥ 213 M	¥ 275 M	¥ 347 M	¥ 387 M	¥ 456 M
Accrued expenses	¥ 803 K	¥ 590 K	¥ 671 K	¥ 100 K	¥ 597 K	¥ 1 M
Deferred tax liabilities					-	¥ 197 K
Advances received	¥ 3 M	¥ 1 M	¥ 2 M	¥ 502 K	¥ 1 M	¥ 2 M
Lease obligations		¥ 1 M	¥ 10 M	¥ 14 M	¥ 22 M	¥ 48 M
Accounts payable-other	¥ 182 M	¥ 250 M	¥ 208 M	¥ 199 M	¥ 261 M	¥ 325 M
Income taxes payable	¥ 20 M	¥ 21 M	¥ 19 M	¥ 24 M	¥ 23 M	¥ 49 M
Accrued consumption taxes	¥ 21 M	¥ 14 M	¥ 33 M	¥ 9 M	¥ 34 M	¥ 286 K
Deposits received	¥ 45 M	¥ 36 M	¥ 47 M	¥ 47 M	¥ 57 M	¥ 50 M
Short-term loans payable	¥ 371 M	¥ 398 M	¥ 430 M	¥ 430 M	¥ 300 M	¥ 400 M
Current portion of long-term loans payable	¥ 568 M	¥ 836 M	¥ 824 M	¥ 755 M	¥ 891 M	¥ 817 M
Current liabilities	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Long-term loans payable	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Lease obligations		¥ 6 M	¥ 43 M	¥ 49 M	¥ 63 M	¥ 117 M
Derivatives liabilities	¥ 39 M	¥ 29 M	¥ 34 M	¥ 34 M	¥ 10 M	-
Deferred tax liabilities					-	¥ 7 M
Noncurrent liabilities	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Liabilities	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Legal capital surplus	¥ 3 B	¥ 3 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 4 B
Other capital surplus					-	¥ 550 K
Capital surplus	¥ 3 B	¥ 3 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 4 B
Retained earnings brought forward	¥ 139 M	¥ -2 B	¥ 372 M	¥ 252 M	¥ 441 M	¥ 604 M
Retained earnings	¥ 1 B	¥ -1 B	¥ 372 M	¥ 252 M	¥ 441 M	¥ 604 M
Treasury stock	¥ -1 M	¥ -42 M	¥ -42 M	¥ -43 M	¥ -43 M	¥ -43 M
Shareholders' equity	¥ 7 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 9 B
Valuation difference on available-for-sale securities	¥ -67 M	¥ -94 M	¥ -47 M	¥ -43 M	¥ 27 M	¥ 86 M
Deferred gains or losses on hedges	¥ -23 M	¥ -29 M	¥ -34 M	¥ -34 M	¥ -10 M	-
Valuation and translation adjustments	¥ -91 M	¥ -124 M	¥ -82 M	¥ -77 M	¥ 16 M	¥ 86 M
Subscription rights to shares	¥ 40 M	¥ 44 M	¥ 43 M	¥ 43 M	¥ 14 M	¥ 14 M
Liabilities and net assets	¥ 9 B	¥ 7 B	¥ 8 B	¥ 7 B	¥ 8 B	¥ 13 B
Investments in capital	¥ 10 K	¥ 10 K
Other				¥ 70 M
Provision for loss on guarantees		¥ 140 M
Legal retained earnings	¥ 106 M	¥ 106 M
General reserve	¥ 1 B	¥ 1 B
Merchandise	¥ 284 M
Finished goods	¥ 337 M
Raw materials	¥ 268 M
Supplies	¥ 41 M
Deferred tax assets	¥ 87 M
Deferred tax assets	¥ 85 M
Non-Consolidated :Income statement (PL) Non-Consolidated | Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Operating income	¥ 115 M	¥ 235 M	¥ 445 M	¥ 325 M	¥ 357 M	¥ 210 M
Ordinary income	¥ 124 M	¥ 263 M	¥ 391 M	¥ 268 M	¥ 362 M	¥ 304 M
Net income	¥ 2 M	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Net sales of goods	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Net sales of finished goods	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Other sales	¥ 37 M	¥ 51 M	¥ 39 M	¥ 38 M	¥ 15 M	¥ 9 M
Cost of sales	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Beginning goods	¥ 299 M	¥ 284 M	¥ 248 M	¥ 255 M	¥ 335 M	¥ 299 M
Cost of purchased goods	¥ 814 M	¥ 823 M	¥ 768 M	¥ 1 B	¥ 965 M	¥ 1 B
Ending goods	¥ 284 M	¥ 248 M	¥ 255 M	¥ 335 M	¥ 299 M	¥ 309 M
Total	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Goods transfer to other account	¥ 35 M	¥ 32 M	¥ 23 M	¥ 19 M	¥ 24 M	¥ 40 M
Cost of goods sold	¥ 794 M	¥ 827 M	¥ 738 M	¥ 941 M	¥ 976 M	¥ 1 B
Beginning finished goods	¥ 346 M	¥ 337 M	¥ 248 M	¥ 265 M	¥ 275 M	¥ 306 M
Cost of products manufactured	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Ending finished goods	¥ 337 M	¥ 248 M	¥ 265 M	¥ 275 M	¥ 306 M	¥ 344 M
Total	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Finished goods transfer to other account	¥ 42 M	¥ 27 M	¥ 41 M	¥ 32 M	¥ 32 M	¥ 33 M
Cost of finished goods sold	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Advertising expenses	¥ 50 M	¥ 46 M	¥ 51 M	¥ 67 M	¥ 68 M	¥ 53 M
Directors' compensations	¥ 141 M	¥ 137 M	¥ 113 M	¥ 126 M	¥ 125 M	¥ 121 M
Welfare expenses	¥ 92 M	¥ 101 M	¥ 105 M	¥ 124 M	¥ 142 M	¥ 143 M
Depreciation	¥ 106 M	¥ 93 M	¥ 63 M	¥ 71 M	¥ 88 M	¥ 125 M
Provision of allowance for doubtful accounts	¥ 43 M	¥ 2 M	¥ 74 M	¥ 23 M	¥ 19 M	¥ 8 M
Research and development expenses	¥ 836 M	¥ 906 M	¥ 917 M	¥ 1 B	¥ 1 B	¥ 963 M
Salaries and allowances	¥ 554 M	¥ 615 M	¥ 668 M	¥ 737 M	¥ 805 M	¥ 832 M
Amortization of goodwill					-	¥ 1 M
Commission fee				¥ 118 M	¥ 166 M	¥ 169 M
Rent expenses	¥ 99 M	¥ 108 M	¥ 107 M	¥ 102 M	¥ 101 M	¥ 114 M
Promotion expenses	¥ 40 M	¥ 34 M	¥ 26 M	¥ 15 M	¥ 14 M	¥ 15 M
Traveling and transportation expenses	¥ 119 M	¥ 118 M	¥ 124 M	¥ 141 M	¥ 163 M	¥ 152 M
Other	¥ 397 M	¥ 401 M	¥ 375 M	¥ 400 M	¥ 281 M	¥ 320 M
Selling, general and administrative expenses	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B
Gross profit	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Interest income	¥ 21 M	¥ 36 M	¥ 17 M	¥ 22 M	¥ 19 M	¥ 17 M
Interest on securities	¥ 16 M	¥ 7 M	¥ 2 M	¥ 2 M	¥ 1 M	¥ 1 M
Foreign exchange gains		¥ 9 M			-	¥ 130 M
Rent income	¥ 10 M	¥ 12 M	¥ 13 M	¥ 13 M	¥ 11 M	¥ 10 M
Compensation income				-	¥ 14 M	-
Insurance premiums refunded cancellation				-	¥ 7 M	-
Dividends income of insurance			¥ 6 M	¥ 4 M	¥ 6 M	¥ 4 M
Other	¥ 7 M	¥ 9 M	¥ 9 M	¥ 8 M	¥ 9 M	¥ 8 M
Non-operating income	¥ 55 M	¥ 76 M	¥ 48 M	¥ 51 M	¥ 72 M	¥ 173 M
Interest expenses	¥ 18 M	¥ 32 M	¥ 42 M	¥ 41 M	¥ 39 M	¥ 35 M
Loss on investments in partnership		¥ 7 M	¥ 23 M	¥ 28 M	¥ 18 M	¥ 11 M
Stock issuance cost					-	¥ 26 M
Foreign exchange losses	¥ 10 M		¥ 28 M	¥ 29 M	¥ 2 M	-
Cost of lease revenue	¥ 14 M	¥ 7 M	¥ 7 M	¥ 6 M	¥ 6 M	¥ 5 M
Other	¥ 3 M	¥ 978 K	¥ 395 K	¥ 2 M	¥ 292 K	¥ 1 M
Non-operating expenses	¥ 46 M	¥ 48 M	¥ 102 M	¥ 108 M	¥ 67 M	¥ 79 M
Gain on sales of investment securities	¥ 7 M	¥ 3 M	¥ 2 M	¥ 3 M	¥ 2 M	¥ 870 K
Gain on reversal of subscription rights to shares		¥ 382 K	¥ 573 K		¥ 29 M	-
Extraordinary income	¥ 30 M	¥ 3 M	¥ 142 M	¥ 3 M	¥ 31 M	¥ 870 K
Loss on retirement of noncurrent assets	¥ 2 M	¥ 24 M	¥ 1 M	¥ 3 M	¥ 2 M	¥ 2 M
Loss on valuation of investment securities		¥ 1 B	¥ 17 M	¥ 10 M	-	¥ 7 M
Loss on valuation of stocks of subsidiaries and affiliates		¥ 694 M	¥ 1 M	¥ 245 M	¥ 113 M	¥ 33 M
Loss on sales of stocks of subsidiaries and affiliates				-	¥ 8 M	-
Extraordinary loss	¥ 119 M	¥ 2 B	¥ 150 M	¥ 310 M	¥ 123 M	¥ 43 M
Income before income taxes	¥ 34 M	¥ -2 B	¥ 383 M	¥ -38 M	¥ 270 M	¥ 261 M
Income taxes	¥ 32 M	¥ 123 M	¥ 10 M	¥ 13 M	¥ 13 M	¥ 28 M
Income taxes-current	¥ 10 M	¥ 10 M	¥ 10 M	¥ 13 M	¥ 13 M	¥ 28 M
Loss on sales of investment securities				¥ 364 K	-
Provision of allowance for doubtful accounts		¥ 359 M	¥ 130 M	¥ 50 M	-
Gain on sales of noncurrent assets			¥ 38 K
Reversal of provision for loss on guarantees			¥ 140 M
Impairment loss		¥ 437 M
Provision for loss on guarantees		¥ 140 M
Loss on valuation of inventories	¥ 117 M	¥ 166 M
Income taxes-deferred	¥ 21 M	¥ 112 M
Gain on sales of subsidiaries and affiliates' stocks	¥ 22 M
Non-Consolidated :Shareowners' equity (SS) Non-Consolidated | Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares					-	¥ 2 B
Total changes of items during the period					-	¥ 2 B
Issuance of new shares					-	¥ 2 B
Total changes of items during the period			¥ -1 B		-	¥ 2 B
Disposal of treasury stock					-	¥ 550 K
Total changes of items during the period					-	¥ 550 K
Issuance of new shares					-	¥ 2 B
Disposal of treasury stock					-	¥ 550 K
Total changes of items during the period			¥ -1 B		-	¥ 2 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Total changes of items during the period	¥ -67 M	¥ -2 B	¥ 3 B	¥ -120 M	¥ 188 M	¥ 163 M
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ 2 M	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Total changes of items during the period	¥ -67 M	¥ -2 B	¥ 1 B	¥ -120 M	¥ 188 M	¥ 163 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 495 K
Total changes of items during the period		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -172 K
Issuance of new shares					-	¥ 4 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ 2 M	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 1 M
Total changes of items during the period	¥ -67 M	¥ -2 B	¥ 372 M	¥ -121 M	¥ 188 M	¥ 4 B
Net changes of items other than shareholders' equity	¥ -49 M	¥ -26 M	¥ 46 M	¥ 4 M	¥ 70 M	¥ 58 M
Total changes of items during the period	¥ -49 M	¥ -26 M	¥ 46 M	¥ 4 M	¥ 70 M	¥ 58 M
Net changes of items other than shareholders' equity	¥ -29 M	¥ -6 M	¥ -4 M	¥ 330 K	¥ 23 M	¥ 10 M
Total changes of items during the period	¥ -29 M	¥ -6 M	¥ -4 M	¥ 330 K	¥ 23 M	¥ 10 M
Net changes of items other than shareholders' equity	¥ -78 M	¥ -32 M	¥ 42 M	¥ 4 M	¥ 94 M	¥ 69 M
Total changes of items during the period	¥ -78 M	¥ -32 M	¥ 42 M	¥ 4 M	¥ 94 M	¥ 69 M
Net changes of items other than shareholders' equity	¥ 15 M	¥ 3 M	¥ -573 K		¥ -29 M	-
Total changes of items during the period	¥ 15 M	¥ 3 M	¥ -573 K		¥ -29 M	-
Issuance of new shares					-	¥ 4 B
Dividends from surplus	¥ -69 M	¥ -69 M		¥ -68 M	¥ -68 M	¥ -68 M
Net income	¥ 2 M	¥ -2 B	¥ 372 M	¥ -51 M	¥ 257 M	¥ 232 M
Purchase of treasury stock		¥ -40 M	¥ -305 K	¥ -690 K	¥ -319 K	¥ -667 K
Disposal of treasury stock					-	¥ 1 M
Net changes of items other than shareholders' equity	¥ -62 M	¥ -29 M	¥ 41 M	¥ 4 M	¥ 64 M	¥ 69 M
Total changes of items during the period	¥ -129 M	¥ -2 B	¥ 413 M	¥ -116 M	¥ 253 M	¥ 4 B
Transfer to other capital surplus from legal capital surplus			¥ -1 B
Transfer to other capital surplus from legal capital surplus			¥ 1 B
Deficit disposition			¥ -1 B
Transfer to other capital surplus from legal capital surplus
Deficit disposition			¥ -1 B
Reversal of legal retained earnings			¥ -106 M
Total changes of items during the period			¥ -106 M
Reversal of general reserve			¥ -1 B
Total changes of items during the period			¥ -1 B
Reversal of legal retained earnings			¥ 106 M
Reversal of general reserve			¥ 1 B
Deficit disposition			¥ 1 B
Deficit disposition			¥ 1 B

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 医学生物学研究所 (Annual )

Statement Type

Annual : 医学生物学研究所

First quarter : 医学生物学研究所

Second quarter : 医学生物学研究所

Third quarter : 医学生物学研究所

Analysis Menu

Outline : 医学生物学研究所

Statement : 医学生物学研究所

Rating : 医学生物学研究所

Indicator : 医学生物学研究所

Download : 医学生物学研究所

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Aichi - EDIUNET Prefectures

Aichi名古屋市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
医学生物学研究所	4557	OSE JASDAQ	Chemicals	3	Annual	A

Related Company

Mitsubishi Gas Chemical (Sales ¥ 467 B)

Sekisui Plastics (Sales ¥ 101 B)

Nihon Tokushu Toryo (Sales ¥ 32 B)

IHARA CHEMICAL INDUSTRY (Sales ¥ 30 B)

IBIDEN (Sales ¥ 285 B)

FUMAKILLA (Sales ¥ 22 B)

ARAKAWA CHEMICAL INDUSTRIES (Sales ¥ 67 B)

イサム塗料 (Sales ¥ 8 B)

医学生物学研究所 (Sales ¥ 6 B)

日華化学 (Sales ¥ 31 B)

堺化学工業 (Sales ¥ 79 B)

TOLI　 (Sales ¥ 84 B)

EARTH CHEMICAL (Sales ¥ 125 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .